CryoPort (CYRX) vs Seaport Therapeutics (SPTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Seaport Therapeutics is the larger company by market cap ($957.1 million vs $853.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYRX | SPTX |
|---|---|---|
| Share price | $16.85 | $17.88 |
| Market cap | $853.44M | $957.13M |
| 1-day change | -2.88% | -0.28% |
| YTD return | +80.73% | — |
| 1-year return | +77.04% | — |
| 5-year return | -75.31% | — |
| EPS (TTM) | $-0.81 | $-5.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.36 | $28.38 |
| 52-week low | $7.61 | $14.85 |
| Distance from 52-week high | -8.22% | -37.00% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +16.74% | +114.15% |
| Average volume | 632.63K | 182.18K |
| Shares outstanding | 50.65M | 53.53M |
| Employees | 684 | 58 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
About Seaport Therapeutics
SPTX stock →Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
CYRX vs SPTX FAQ
Which is bigger, CryoPort or Seaport Therapeutics?
Seaport Therapeutics (SPTX) is larger, with a market capitalization of $957.13M compared with $853.44M for CryoPort (CYRX).
Are CryoPort and Seaport Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.